Bupropion Hydrochloride
- Product NDC
- 0115-6811
- 11-digit product format
- 001156811
- Labeler code
- 0115
- Product ID
- 0115-6811_5fb023e1-b35a-40c0-a5aa-1e383dcd4d86
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- BUPROPION HYDROCHLORIDE
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Application
- ANDA077415
- Marketing category
- ANDA
- Marketing start
- 2009-05-01
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bupropion Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUPROPION HYDROCHLORIDE | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ZG7E5POY8O |
| Rxcui | 993541 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0115-6811-02 | Bupropion Hydrochloride | 500 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 500 | | 21 |
| 0115-6811-08 | Bupropion Hydrochloride | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | | 21 |
| 0115-6811-10 | Bupropion Hydrochloride | 90 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 90 | | 21 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| BUPROPION HYDROCHLORIDE | ACTIVE INGREDIENT | ZG7E5POY8O | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| BUPROPION | ACTIVE MOIETY | 01ZG3TPX31 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| FD&C YELLOW NO. 5 | INACTIVE INGREDIENT | I753WB2F1M | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| POLYDEXTROSE | INACTIVE INGREDIENT | VH2XOU12IE | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| TRIACETIN | INACTIVE INGREDIENT | XHX3C3X673 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.] | 3 | |
| BUPROPION HYDROCHLORIDE | ACTIVE INGREDIENT | ZG7E5POY8O | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| BUPROPION | ACTIVE MOIETY | 01ZG3TPX31 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| FD&C YELLOW NO. 5 | INACTIVE INGREDIENT | I753WB2F1M | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| POLYDEXTROSE | INACTIVE INGREDIENT | VH2XOU12IE | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
| TRIACETIN | INACTIVE INGREDIENT | XHX3C3X673 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [MEDSOURCE PHARMACEUTICALS] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0115-6811 | BUPROPION HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] | 21 | Current NDC, Legacy NDC, 3 package rows | 20250328_fddc9630-2f9a-4104-888f-3714587d4fe7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0115-6811-02 | 00115681102 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-02) | 2009-05-01 | 0000-00-00 | No | No | Current |
| 0115-6811-08 | 00115681108 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-08) | 2009-05-01 | 0000-00-00 | No | No | Current |
| 0115-6811-10 | 00115681110 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-6811-10) | 2009-05-01 | 0000-00-00 | No | No | Current |